GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.500
+0.020 (0.57%)
At close: Aug 12, 2025, 4:00 PM
3.470
-0.030 (-0.86%)
Pre-market: Aug 13, 2025, 5:00 AM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.33 billion as of August 13, 2025. Its market cap has decreased by -60.02% in one year.
Market Cap
1.33B
Enterprise Value
1.59B
1-Year Change
-60.02%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.33B, a decrease of -89.52%. That is a compound annual growth rate of -36.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.33B | -25.80% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
| Sep 23, 2020 | 12.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |